137 related articles for article (PubMed ID: 18609530)
1. The effect of hemoglobin level on arteriovenous fistula survival in Iranian hemodialysis patients.
Khavanin Zadeh M; Gholipour F; Hadipour R
J Vasc Access; 2008; 9(2):133-6. PubMed ID: 18609530
[TBL] [Abstract][Full Text] [Related]
2. Haemoglobin level and vascular access survival in haemodialysis patients.
Garrancho JM; Kirchgessner J; Arranz M; Klinkner G; Rentero R; Ayala JA; Marcelli D
Nephrol Dial Transplant; 2005 Nov; 20(11):2453-7. PubMed ID: 16077146
[TBL] [Abstract][Full Text] [Related]
3. Patients started on hemodialysis with tunneled dialysis catheter have similar survival after arteriovenous fistula and arteriovenous graft creation.
Yuo TH; Chaer RA; Dillavou ED; Leers SA; Makaroun MS
J Vasc Surg; 2015 Dec; 62(6):1590-7.e2. PubMed ID: 26372193
[TBL] [Abstract][Full Text] [Related]
4. Risk Factors for Primary Arteriovenous Fistula Dysfunction in Hemodialysis Patients: A Retrospective Survival Analysis in Multiple Medical Centers.
Wen M; Li Z; Li J; Zhou W; Liu Y; Liu H; Chen G
Blood Purif; 2019; 48(3):276-282. PubMed ID: 31067537
[TBL] [Abstract][Full Text] [Related]
5. Vascular access use in Europe and the United States: results from the DOPPS.
Pisoni RL; Young EW; Dykstra DM; Greenwood RN; Hecking E; Gillespie B; Wolfe RA; Goodkin DA; Held PJ
Kidney Int; 2002 Jan; 61(1):305-16. PubMed ID: 11786113
[TBL] [Abstract][Full Text] [Related]
6. Vascular access for hemodialysis: the impact on morbidity and mortality.
Di Iorio BR; Bellizzi V; Cillo N; Cirillo M; Avella F; Andreucci VE; De Santo NG
J Nephrol; 2004; 17(1):19-25. PubMed ID: 15151255
[TBL] [Abstract][Full Text] [Related]
7. Serum LDL levels are a major prognostic factor for arteriovenous fistula thrombosis (AVFT) in hemodialysis patients.
Serati AR; Roozbeh J; Sagheb MM
J Vasc Access; 2007; 8(2):109-14. PubMed ID: 17534797
[TBL] [Abstract][Full Text] [Related]
8. Reaching target hemoglobin level and having a functioning arteriovenous fistula significantly improve one year survival in twice weekly hemodialysis.
Elamin S; Abu-Aisha H
Arab J Nephrol Transplant; 2012 May; 5(2):81-6. PubMed ID: 22612193
[TBL] [Abstract][Full Text] [Related]
9. Risk factors of vascular access failure in patients on hemodialysis.
Gheith OA; Kamal MM
Iran J Kidney Dis; 2008 Oct; 2(4):201-7. PubMed ID: 19377238
[TBL] [Abstract][Full Text] [Related]
10. Comorbid conditions and gender impact the primary survival of distal radio-cephalic arteriovenous fistula inpatients on long-term hemodialysis.
Vernaglione L; Mele G; Cristofano C; Distratis C; Perrone F; Frascina M; Pennacchiotti F; Chimienti S
J Nephrol; 2005; 18(3):276-81. PubMed ID: 16013015
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Outcomes with Arteriovenous Fistula and Arteriovenous Graft for Vascular Access in Hemodialysis: A Prospective Cohort Study.
Park HS; Kim WJ; Kim YK; Kim HW; Choi BS; Park CW; Kim YO; Yang CW; Kim YL; Kim YS; Kang SW; Kim NH; Jin DC
Am J Nephrol; 2016; 43(2):120-8. PubMed ID: 27022896
[TBL] [Abstract][Full Text] [Related]
12. Association between post-dialysis hemoglobin level and the survival of vascular access.
Nishiwaki H; Hasegawa T; Ikenoue T; Tominaga N; Yazawa M; Kawarazaki H; Shibagaki Y; Yamamoto Y; Fukuma S; Yamazaki S; Fukuhara S
J Vasc Access; 2018 Jan; 19(1):69-75. PubMed ID: 29076517
[TBL] [Abstract][Full Text] [Related]
13. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
[TBL] [Abstract][Full Text] [Related]
14. Efficiency of the kidney disease outcomes quality initiative guidelines for preemptive vascular access in an academic setting.
Kimball TA; Barz K; Dimond KR; Edwards JM; Nehler MR
J Vasc Surg; 2011 Sep; 54(3):760-5; discussion 765-6. PubMed ID: 21703804
[TBL] [Abstract][Full Text] [Related]
15. Predictive Factors for Unsuccessful Use of Arteriovenous Fistula in a Population of End-Stage Renal Disease Patients in Southeastern Mexico.
Martinez-Mier G; Camargo-Diaz C; Urbina-Velazquez MA; Avila-Pardo SF
Ann Vasc Surg; 2020 Jan; 62():304-309. PubMed ID: 31449952
[TBL] [Abstract][Full Text] [Related]
16. Survival of primary arteriovenous fistula in 463 patients on chronic hemodialysis.
Puskar D; Pasini J; Savić I; Bedalov G; Sonicki Z
Croat Med J; 2002 Jun; 43(3):306-11. PubMed ID: 12035137
[TBL] [Abstract][Full Text] [Related]
17. Hemoglobin predicts long-term survival in dialysis patients: a 15-year single-center longitudinal study and a correlation trend between prealbumin and hemoglobin.
Avram MM; Blaustein D; Fein PA; Goel N; Chattopadhyay J; Mittman N
Kidney Int Suppl; 2003 Nov; (87):S6-11. PubMed ID: 14531767
[TBL] [Abstract][Full Text] [Related]
18. The middle-arm fistula as a valuable surgical approach in patients with end-stage renal disease.
Bonforte G; Rossi E; Auricchio S; Pogliani D; Mangano S; Mandolfo S; Galli F; Genovesi S
J Vasc Surg; 2010 Dec; 52(6):1551-6. PubMed ID: 20800416
[TBL] [Abstract][Full Text] [Related]
19. Multifactorial analysis of renal anemia-associated substandard hemoglobin levels and prevalence of anemia in patients on maintenance hemodialysis in Liaoning Province: a cross-sectional study.
Yin S; Du Y; Guo Y; Guo G; Sun D; Yao L
Ann Palliat Med; 2022 Dec; 11(12):3743-3754. PubMed ID: 36635999
[TBL] [Abstract][Full Text] [Related]
20. The Korean Clinical Research Center for End-Stage Renal Disease Study Validates the Association of Hemoglobin and Erythropoiesis-Stimulating Agent Dose with Mortality in Hemodialysis Patients.
Kwon O; Jang HM; Jung HY; Kim YS; Kang SW; Yang CW; Kim NH; Choi JY; Cho JH; Kim CD; Kim YL; Park SH;
PLoS One; 2015; 10(10):e0140241. PubMed ID: 26452232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
